Health ❯Healthcare ❯Regulatory Affairs

FDA

Drug Approval Process Emergency Use Authorization Medical Approvals Over-the-Counter Products Drug Labeling Drug Development Vaccine Approval Inspections Breakthrough Therapy Designation Expiration Dates Drug Shortages Drug Clearance Consumer Safety Product Recalls Drug Applications Drug Warnings Drug Efficacy Clinical Holds

FDA Declares Semaglutide Shortage Over, Impacting Compounded Drug Market

Biogen Reports Mixed Q4 Results and Lowers 2025 Outlook

Systane Eye Drops Recalled Over Potential Fungal Contamination

Systane Eye Drops Recalled Nationwide Over Fungal Contamination Risk

FDA Proposes Removal of Ineffective Oral Phenylephrine from Cold Medicines

Ozempic and Wegovy Now Available After Prolonged Shortages

FDA Halts Novavax's COVID-Flu Combo Vaccine Trial Over Safety Concerns

Boehringer Ingelheim's Survodutide Wins FDA Breakthrough Status for MASH Treatment

Thermo Fisher's Greenville Plant Cited for FDA Rule Breaches

Pfizer Withdraws Sickle Cell Drug Oxbryta Over Safety Concerns

FDA Approves First At-Home Nasal Spray Flu Vaccine

Study Finds CAR-T Therapy Does Not Increase Risk of Secondary Cancer

New Study Links Ozempic to Increased Risk of Suicidal Thoughts

Eli Lilly's Zepbound Shows Promise in Reducing Heart Failure Risks

FDA Issues Warning on Overdoses from Compounded Semaglutide Injections